Published in Gene Therapy Weekly, January 13th, 2000
David T. Curiel, representing colleagues from the Gene Therapy Center at the University of Alabama, reported on the development and modification of adenoviral vectors for gene therapy at the conference Gene Therapy: Delivering the Medicines of the 21st Century, held November 7-9, 1999, in Washington, DC. The title of his presentation was "CAR-Independent Gene Transfer to Accomplish Efficient, and Specific Genetic Modification of Target Cells Via Adenoviral Vectors."
"Adenoviruses have been widely employed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.